Resources
Here you can find a summary of something interesting to share with a colleague, download a pitch deck to use internally, or find a quarterly update to include in your reports.
If you’re one of our fantastic partners, you can also use this information to share with your customers and colleagues.
Loba Biotech GmbH Selects CARA Life Sciences Platform for Digital Quality Management
Loba biotech GmbH, a wholly owned GMP manufacturing subsidiary of pharmaand GmbH (pharma&), has chosen Generis’ CARA Life Sciences Platform to launch its digital Quality Management System (QMS). The initial phase will focus on digitalizing Standard Operating Procedures (SOPs) and implementing the training module, with a go-live target set for
CARA Platform Gains Global Momentum as Generis Unlocks Record Implementation Speeds
AI-powered CARA Platform and new Starter Pack Model fuel rapid expansion across regulated sectors LONDON, UK – Generis, creator of the CARA Platform and CARA Life Sciences Platform, is continuing to accelerate its momentum across both Life Sciences and a growing portfolio of other highly regulated industries. Known for its
Latest Resources
Loba Biotech GmbH Selects CARA Life Sciences Platform for Digital Quality Management
Loba biotech GmbH, a wholly owned GMP manufacturing subsidiary of pharmaand GmbH (pharma&), has chosen Generis’ CARA Life Sciences Platform to launch its digital Quality Management System (QMS). The initial phase will focus on digitalizing Standard Operating Procedures (SOPs) and implementing the training module, with a go-live target set for
CARA Platform Gains Global Momentum as Generis Unlocks Record Implementation Speeds
AI-powered CARA Platform and new Starter Pack Model fuel rapid expansion across regulated sectors LONDON, UK – Generis, creator of the CARA Platform and CARA Life Sciences Platform, is continuing to accelerate its momentum across both Life Sciences and a growing portfolio of other highly regulated industries. Known for its
AI for LifeSciences – Data & Documentation
Life sciences runs on documentation and data. AI is changing how we manage it. From regulatory filings to clinical research, data is growing exponentially. AI is the key to structuring, retrieving, and using it efficiently. In a rapidly evolving global market, Generis’ latest AI innovations are advancing operational efficiency, compliance,
Cytonics Selects CARA Life Sciences Platform for Rapid eTMF System Implementation
Cytonics, a biotechnology research and development company specializing in diagnostics and therapeutics for osteoarthritis, has selected Generis, the provider of the AI-enabled CARA Life Sciences Platform, to manage its electronic Trial Master File (eTMF) and enhance operational efficiency and productivity. Faced with a need for rapid implementation, Cytonics sought a
Kwizda Pharma Adopts CARA Life Sciences Platform for Rapid QMS Implementation with Minimal IT Resources
Kwizda Pharma, a division of Kwizda Holding GmbH and a leader in the Austrian healthcare market, has selected the CARA Life Sciences Platform from Generis, leading provider of CARA Platform for Content and Data management, to digitise and streamline Quality processes. With over 170 years of experience in the pharmaceutical
eTMF Archive on the CARA Life Sciences Platform
eTMF Archive on the CARA Life Sciences Platform The CARA Life Sciences Platform offers a comprehensive Electronic Trial Master File (eTMF) Archive, designed to enhance the management, accessibility, and compliance of your clinical documentation. By integrating advanced automation, seamless collaboration, and robust compliance features, CARA empowers life sciences companies to
Generis Introduces Game-Changing AI Capabilities in CARA 5.13 Release
LONDON, UK – 7th April 2025 – Generis, a global leader in content and data management, announces the release of CARA 5.13, the latest version of its industry-leading platform. This new release integrates cutting-edge artificial intelligence (AI) capabilities, including “Chat with Your Data,” an innovative feature designed to revolutionise how
Generis and Regenold Partner to Transform Regulatory and Quality Management in the Medical Device Industry
31/03/2025 – London UK – Generis, creator of leading life sciences platform CARA, and Regenold GmbH, a specialist in regulatory affairs and quality management for medical devices, have partnered to revolutionise the way medical device companies manage Regulatory Information and Quality. This strategic partnership will enable medical device organisations to
